1OHR | Aspartyl Protease | date | Sep 27, 1997 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Viracept (R) (Nelfinavir Mesylate, Ag1343): A Potent Orally Bioavailable Inhibitor Of Hiv-1 Protease | ||||||||||||||
authors | J.F.Davies Ii | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Aspartylprotease Chain: A, B Engineered: Yes Other_details: Complexed With Viracept |
Organism_scientific: Human Immunodeficiency Virus 1 Organism_taxid: 11676 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.10 Å | ||||||||||||
ligand | 1UN BindingDB | enzyme |
| ||||||||||||
note | 1OHR (Molecule of the Month:pdb6) | ||||||||||||||
related structures | by homologous chain: 1EC1, 1LV1 | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease., Kaldor SW, Kalish VJ, Davies JF 2nd, Shetty BV, Fritz JE, Appelt K, Burgess JA, Campanale KM, Chirgadze NY, Clawson DK, Dressman BA, Hatch SD, Khalil DA, Kosa MB, Lubbehusen PP, Muesing MA, Patick AK, Reich SH, Su KS, Tatlock JH, J Med Chem 1997 Nov 21;40(24):3979-85. PMID:9397180 |
Data retrieval |
View 1OHR in 3D |
Visual 3D analysis of 1OHR |
Structure-derived information |
- Domain d1ohra_, region A [Jmol] [rasmolscript] [script source] - Domain d1ohrb_, region B [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1OHR |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |